跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 96,236 条关于
“KRAS-mutant colon cancer”
全部
96,236
临床试验
77,693
药物
2,536
机构
1,106
资讯
14,901
去年
SEED Therapeutics Receives FDA Clearance for First-in-Human Trial of RBM39 Degrader ST-01156
10个月前
SEED Therapeutics Receives China NMPA Clearance for ST-01156 Molecular Glue Degrader in Rare Cancer Trial
16年前
KRAS Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803
9个月前
Pelareorep Shows 33% Response Rate in KRAS-Mutant Colorectal Cancer, Tripling Standard-of-Care Outcomes
去年
RMC-9805 Demonstrates Promising Activity in KRAS G12D-Mutated Pancreatic Cancer
去年
Verastem's Avutometinib and Defactinib Combination Receives FDA Priority Review for Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer
去年
Amgen Develops Pan-KRAS Inhibitor AMG 410 to Target Broader Range of KRAS-Mutant Tumors
去年
Revolution Medicines Reports Promising Results for Zoldonrasib in KRAS G12D Mutant Lung Cancer
10个月前
Kazakhstan's Anti-Cancer Drug Targeting KRAS-Mutant Tumors Advances to Phase 2026 Clinical Trials
3天前
FDA Grants Fast Track Designation to Kestrel's Oral Pan-KRAS Inhibitor KST-6051 for KRAS-Mutant Solid Tumors
第 1 页,共 1491 页
上一页
下一页